ArticlePloS one2016

Significantly Reduced Genoprevalence of Vaccine-Type HPV-16/18 Infections among Vaccinated Compared to Non-Vaccinated Young Women 5.5 Years after a Bivalent HPV-16/18 Vaccine (Cervarix®) Pilot Project in Uganda.

Edward Kumakech et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.